Your browser doesn't support javascript.
loading
FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells.
Weisbrod, Luisa; Capriotti, Luigi; Hofmann, Marco; Spieler, Valerie; Dersch, Herbert; Voedisch, Bernd; Schmidt, Peter; Knake, Susanne.
Afiliación
  • Weisbrod L; Recombinant Protein Discovery, CSL Innovation GmbH, Marburg, Germany.
  • Capriotti L; Analytical Biochemistry, Research and Development, CSL Behring AG, Bern, Switzerland.
  • Hofmann M; Recombinant Protein Discovery, CSL Innovation GmbH, Marburg, Germany.
  • Spieler V; Recombinant Protein Discovery, CSL Innovation GmbH, Marburg, Germany.
  • Dersch H; Recombinant Protein Discovery, CSL Innovation GmbH, Marburg, Germany.
  • Voedisch B; Recombinant Protein Discovery, CSL Innovation GmbH, Marburg, Germany.
  • Schmidt P; Protein Biochemistry, Bio21 Institute, CSL Limited, Parkville, VIC, Australia.
  • Knake S; Department of Neurology, Epilepsy Center Hessen, Philipps University Marburg, Marburg, Germany.
Front Immunol ; 15: 1386160, 2024.
Article en En | MEDLINE | ID: mdl-38779658
ABSTRACT
The study of peptide repertoires presented by major histocompatibility complex (MHC) molecules and the identification of potential T-cell epitopes contribute to a multitude of immunopeptidome-based treatment approaches. Epitope mapping is essential for the development of promising epitope-based approaches in vaccination as well as for innovative therapeutics for autoimmune diseases, infectious diseases, and cancer. It also plays a critical role in the immunogenicity assessment of protein therapeutics with regard to safety and efficacy concerns. The main challenge emerges from the highly polymorphic nature of the human leukocyte antigen (HLA) molecules leading to the requirement of a peptide mapping strategy for a single HLA allele. As many autoimmune diseases are linked to at least one specific antigen, we established FASTMAP, an innovative strategy to transiently co-transfect a single HLA allele combined with a disease-specific antigen into a human cell line. This approach allows the specific identification of HLA-bound peptides using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Using FASTMAP, we found a comparable spectrum of endogenous peptides presented by the most frequently expressed HLA alleles in the world's population compared to what has been described in literature. To ensure a reliable peptide mapping workflow, we combined the HLA alleles with well-known human model antigens like coagulation factor VIII, acetylcholine receptor subunit alpha, protein structures of the SARS-CoV-2 virus, and myelin basic protein. Using these model antigens, we have been able to identify a broad range of peptides that are in line with already published and in silico predicted T-cell epitopes of the specific HLA/model antigen combination. The transient co-expression of a single affinity-tagged MHC molecule combined with a disease-specific antigen in a human cell line in our FASTMAP pipeline provides the opportunity to identify potential T-cell epitopes/endogenously processed MHC-bound peptides in a very cost-effective, fast, and customizable system with high-throughput potential.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mapeo Epitopo / Epítopos de Linfocito T / Proteómica / Antígenos HLA-E Límite: Humans Idioma: En Revista: Front Immunol Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mapeo Epitopo / Epítopos de Linfocito T / Proteómica / Antígenos HLA-E Límite: Humans Idioma: En Revista: Front Immunol Año: 2024 Tipo del documento: Article País de afiliación: Alemania
...